Skip to content

Recall watch for the stuff you own · As an Amazon Associate we earn from qualifying purchases · Some links earn a commissionDisclosure

Consumer Sun

FDAFDA recall Z-2741-2026 · Jul 22, 2026

Maquet Cardiovascular, LLC: The Vasoview Hemopro 2 Endoscopic Vessel Harvesting System (Model VH-4000 recall

Recall found

Product

The Vasoview Hemopro 2 Endoscopic Vessel Harvesting System (Model VH-4000; UDI 00607567700406) is a sterile, single-use Class II device that was cleared for marketing by FDA under 510(k) number K101274.

Reason for recall

Getinge identified that Vasoview Hemopro 2 devices from Lot 3000547797 were exposed to an out-of-specification sterilization dose during a gamma sterilization run (Run ID 1183-28782A) performed by STERIS at its Whippany, NJ facility between March 31 and April 1 of 2026.

What to do

FDA enforcement reports don't include consumer instructions. Check the codes below against your packaging. If this is a medicine or device you use, talk to your pharmacist or doctor before you stop or change anything, and contact the company or FDA for what to do with the product.

Recall details

FDA classification
Class II: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Status
Ongoing
Codes, lots and dates
UDI 00607567700406, Serial/Lot Number 3000547797
Quantity
205 units
Distribution
US Nationwide distribution in the states of NY, CA, SC, FL, TX, GA, OR.
Recalling firm
Maquet Cardiovascular, LLC, Wayne, NJ
Voluntary or mandated
Voluntary: Firm initiated
Recall started
2026-06-02

Source: openFDA enforcement record Z-2741-2026 · search recall number Z-2741-2026 in FDA's Enforcement Report.

Copied from the agency record without changes. Data as of Oct 22, 2026, 4:56 AM EDT. The agency notice is the final word.

Watch my items

Get an email when new recalls are posted for the kinds of things you own. Just your first name and email, nothing else.

Unsubscribe any time with one click. We never share your address.